ARTELO BIOSCIENCES, INC. (ARTL) [Rocket]

Overview

ARTELO BIOSCIENCES, INC. (ARTL)

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
08/10/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/08/2023	4	MATSUI CONNIE (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
08/08/2023	4	Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2023	4	Reyes Gregory (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
08/08/2023	4	EMANUELE ROBERT MARTIN (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
08/08/2023	4	Kelly Steven (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
08/08/2023	4	FAVORITO TAMARA A (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Aug-31-21	Aug-31-20	Aug-31-19	Aug-31-18	Aug-31-17	Aug-31-16	Aug-31-15
Revenues	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
Revenue growth					-100.0%	684.1%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin						0.0%	0.0%
Selling, general and administrative								0.0
Research and development	4.3	2.8	1.9	1.1	1.2
General and administrative	6.0	4.6	2.8	2.1	1.1	0.2	0.0	0.0
EBIT	-10.3	-7.4	-4.7	-3.2	-2.3	-0.2	0.0	0.0
EBIT margin						-100.0%	-100.0%
Pre-tax income	-10.1	-7.4	-4.7	-2.2	-2.3	-0.2	0.0	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-10.1	-7.4	-4.7	-2.2	-2.3	-0.2	0.0	0.0
Net margin						-100.9%	-100.0%

Diluted EPS	($3.56)	($5.97)	($1.26)	($1.00)	($1.83)	($0.03)	$0.00	$0.00
Shares outstanding (diluted)	2.8	1.2	3.7	2.2	1.3	8.7	7.6	6.4

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.